Uncomplicated common bile duct stone removal guided by cholangioscopy versus conventional endoscopic retrograde cholangiopancreatography
Although previous studies have reported the possibility of therapeutic ERCP without fluoroscopy, more robust documentation of fluoroscopy-free common bile duct stone (CBDS) clearance is needed. Technically, “digital cholangioscopy” (DCS) may be used to confirm CBDS clearance. We aimed to compare the feasibility, safety, and radiation exposure between patients with CBDS undergoing stone removal by DCS and conventional ERCP (cERCP).
Fifty (50) consecutive patients with a CBDS size < 15 mm underwent DCS (SpyGlass DS Direct Visualization System, Boston Scientific, Marlboro, MA, USA) between December 2015 and October 2016. Of 202 consecutive patients undergoing cERCP during the same time frame, 50 matched pairs were created using propensity score matching analysis. In the DCS group, patients underwent biliary cannulation and CBDS removal without fluoroscopy followed by DCS to confirm complete CBDS clearance. A final occlusion cholangiogram was performed as the current standard of care to confirm CBDS clearance.
Cannulation success rates were similar between the DCS and cERCP groups (98 vs. 98%). By intention-to-treat analysis, CBDS clearance in the DCS and cERCP groups was not different (90 vs. 98%; p = 0.20, respectively). DCS had successful CBDS removal in 45 cases, whereas 5 (10%) failed for clearance by DCS due to technical limitations. Adverse events were not different between both groups.
In the management of uncomplicated CBDS, our data confirmed the feasibility of DCS for CBDS clearance as it showed efficacy and safety comparable to those of cERCP. Although certain conditions may limit its effectiveness, DCS offers the ability to perform CBDS clearance without the need for fluoroscopy unit and can avoid radiation exposure while ERCP under fluoroscopy remains the current standard of care in patients with CBDS.
KeywordsEndoscopic retrograde cholangiopancreatography Cholangioscopy Non-radiation Fluoroscopy
Endoscopic retrograde cholangiopancreatography
Common bile duct stone
Dose area product
Magnetic resonance cholangiopancreatography
American Society for Gastrointestinal Endoscopy
Compliance with ethical standards
Wiriyaporn Ridtitid, Thanawat Luangsukrerk, Phonthep Angsuwatcharakon, Panida Piyachaturawat, Prapimphan Aumpansub, Cameron Hurst, Roongruedee Chaiteerakij, Pradermchai Kongkam, and Rungsun Rerknimitr have no conflict of interest or financial ties to disclose.
- 2.Committee AT, Pedrosa MC, Farraye FA, Shergill AK, Banerjee S, Desilets D, Diehl DL, Kaul V, Kwon RS, Mamula P, Rodriguez SA, Varadarajulu S, Song LM, Tierney WM (2010) Minimizing occupational hazards in endoscopy: personal protective equipment, radiation safety, and ergonomics. Gastrointest Endosc 72:227–235CrossRefGoogle Scholar
- 6.Sharma SS, Maharshi S (2008) Two stage endoscopic approach for management of choledocholithiasis during pregnancy. J Gastrointest Liver Dis 17:183–185Google Scholar
- 14.Committee ASoP, Maple JT, Ikenberry SO, Anderson MA, Appalaneni V, Decker GA, Early D, Evans JA, Fanelli RD, Fisher D, Fisher L, Fukami N, Hwang JH, Jain R, Jue T, Khan K, Krinsky ML, Malpas P, Ben-Menachem T, Sharaf RN, Dominitz JA (2011) The role of endoscopy in the management of choledocholithiasis. Gastrointest Endosc 74:731–744CrossRefGoogle Scholar
- 16.Netinatsunton N, Sottisuporn J, Attasaranya S, Witeerungrot T, Siripun A, Pattarapuntakul T, Ovartlarnporn B (2017) Prospective randomized trial of EUS-assisted ERCP without fluoroscopy versus ERCP in common bile duct stone. Gastrointest Endosc. https://doi.org/10.1016/j.gie.2017.03.1539 PubMedGoogle Scholar